Breast Cancer Therapy
Researchers from Royal Marsden Hospital report details of new studies and findings in the area of breast cancer therapy
Published in Disease Risk Factor Week, January 27th, 2008
A new study, 'Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer,' is now available. According to recent research from Sutton, the United Kingdom, "Anthracyclines and taxanes are among the most active substances used in the treatment of metastatic breast cancer (MBC). Their frequent use in the adjuvant setting and in cumulative toxicities including cardiotoxicity, however, often limit their use in MBC."
"The trend towards the use of adjuvant trastuzumab-containing regimens, which can also produce cardiotoxicity, adds further support to the need for effective agents with improved tolerability in the metastatic setting. Pegylated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Abdominal Aortic Aneurysm Genetics
Investigators at King's College London, Cardiovascular Division have published new data on abdominal aortic aneurysm genetics - Acromegaly
Studies conducted at M. Andreassen et al on acromegaly recently published - Acute Hepatitis
Scientists at University of Washington report research in acute hepatitis - Adrenal Insufficiency
Research on adrenal insufficiency discussed by scientists at University of Alabama - Adverse Drug Reactions
Researchers at La Paz University target adverse drug reactions - Aetna
Aetna to Announce Fourth Quarter and Full-Year 2007 Results - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
